10:25 AM EDT, 07/02/2024 (MT Newswires) -- Biogen (BIIB) said Tuesday it has completed the acquisition of privately-held clinical-stage biotechnology firm Human Immunology Biosciences.
Financial details were not disclosed.
Biogen stock was down 0.8% in recent trading.
Price: 229.75, Change: -2.03, Percent Change: -0.87